Engage Bio
San Carlos
About Engage Bio
Engage Bio is developing mRNA treatments that change cancer cells into production facilities for immunotherapies. With the help of these treatments, the immune system is activated and directed toward the tumour.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $3.9M
- Funding stage: Seed
- Last round: Seed (May 2022)
- Website: engagebio.com
- Phone: [email protected]
Industries & Categories
Biotechnology, Health Care, Therapeutics
Social Profiles
Canonical: https://fsome.com/organization/engage-bio-9119 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.